Thromboxane biosynthesis and future events in diabetes: the ASCEND trial

Medicine and Dentistry

• Diabetes 100%
• Revascularization 100%
• Thromboxane 100%
• Acetylsalicylic Acid 80%
• Malignant Neoplasm 60%
• Ciclonicate 60%
• Maturity Onset Diabetes of the Young 40%
• Thrombosis 40%
• Hazard Ratio 40%
• Patient with Diabetes 40%
• Thrombocyte Activation 40%
• Urinary System 40%
• Inpatient 40%
• Follow up 20%
• Platelet 20%
• Diabetes Mellitus 20%
• Insulin Dependent Diabetes Mellitus 20%
• Creatinine 20%
• Metabolite 20%
• Cardiovascular Disease 20%
• Biological Marker 20%
• Low Drug Dose 20%
• Thromboxane A2 20%
• Major Bleeding 20%
• Proportional Hazards Model 20%
• Glomerular Filtration Rate 20%
• Placebo 20%

Biochemistry, Genetics and Molecular Biology

• Low Drug Dose 50%
• Glomerulus Filtration 50%
• Body Size 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Ciclonicate 60%
• Thromboxane A2 20%